Taken together, these results suggest that disturbances in brain glucose metabolism and/or insulin signaling induced by APOE isoforms may be key to understanding the mechanisms of neurodegenerative changes in individuals with cognitive impairment. The gene discussed is APOE; the disease is Cognitive impairment.